Working… Menu

Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Participants With Previously Untreated Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02252172
Recruitment Status : Active, not recruiting
First Posted : September 30, 2014
Last Update Posted : March 8, 2019
Information provided by (Responsible Party):
Janssen Research & Development, LLC